go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Amgen Ltd
240 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0WD , UK
Telephone: +44 (0)1223 420 305
Fax: +44 (0)1223 426 314
Medical Information Direct Line: +44 (0)1223 436 441/Freephone: 1800 523137
Medical Information e-mail: gbinfoline@amgen.com
Customer Care direct line: +44 (0)1223 436 700/Freephone: 1800 523137
Patient Information Leaflet last updated on medicines.ie: 21/11/2011
PIL Vectibix

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 21/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to how the medicine works
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 03/06/2011 and displayed until 21/11/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 26/05/2010 and displayed until 03/06/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 12/05/2010 and displayed until 26/05/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
Updated on 23/04/2009 and displayed until 12/05/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 21/01/2009 and displayed until 23/04/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 28/08/2008 and displayed until 21/01/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/07/2008 and displayed until 28/08/2008
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Panitumumab